Ironwood Pharmaceuticals, Inc. (IRWD)
4.57
+0.07
(+1.56%)
USD |
NASDAQ |
Jan 20, 16:00
4.58
+0.01
(+0.22%)
After-Hours: 20:00
Ironwood Pharmaceuticals EPS Diluted (Quarterly): 0.2294 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| Outlook Therapeutics, Inc. | -0.5453 |
| Nektar Therapeutics | -1.875 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 40.08M |
| Revenue (Quarterly) | 122.06M |
| Total Expenses (Quarterly) | 81.98M |
| Enterprise Value | 1.190B |
| Gross Profit Margin (Quarterly) | 99.61% |
| Profit Margin (Quarterly) | 32.84% |
| Earnings Yield | 3.38% |
| Operating Earnings Yield | 18.84% |
| Normalized Earnings Yield | 5.319 |